Azelis’ €200 Million Capital Increase

Clifford Chance advised Azelis. Azelis, a leading global innovation service provider in the specialty chemicals and food ingredients industry listed on the regulated market of Euronext...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Nicox’s €10 Million Capital Increase

Clifford Chance advised Nicox on the deal. Nicox, an international company specializing in ophthalmology, raised funds by private placement of 6,849,316 new shares, each accompanied by...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Lucas Bols’ EUR29 Million Capital Raise

Clifford Chance advised the Joint Global Coordinators and Joint Bookrunners on the matter. ABN AMRO Bank N.V. and Coöperatieve Rabobank U.A. acted as Joint Global Coordinators...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Nicox’ €15 Million Private Placement

Clifford Chance advised Nicox on the deal. Nicox, an international ophthalmology company, completed a financing through a private placement of 6,000,000 new shares with warrants attached...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here